Preliminary studies have been conducted on various parameters in order to assess the possible and relative toxicities of a number of metallic salts. Upon oral administration in lethal-dose experiments, two soluble Pt4+ salts were more toxic than the other salts tested. Following intraperitoneal injection in lethal-dose experiments, PbC1, was less toxic than several of the soluble or partially soluble salts of Pt'+, Pd2+, and Mn'+. An intake of a total of approximately 250 mg of Pt4+ per rat in the drinking fluid over a 30-day interva&l did not affect the activities of aniline hydroxylase and aminopyrine demethylase in rat liver microsomes. In rats receiving soluble Pt4+ salts in the drinking fluid, the highest concentration of Pt was found in the kidney and an appreciable concentration was found in the liver.
Introduction
Preliminary studies have been conducted on various parameters in order to assess the possible and relative toxicities of a number of metallic salts. The chloride, sulfate, and oxide salts of lead, manganese, platinum, and palladium were studied, since it is considered that some of these salts may be included in automotive emission products.
In the lethal dose experiments, the salts were administered orally (via stomach tube) or intraperitoneally. The rats were observed through a 14-day observation period. In the completed experiments, the LD50 values were calculated by the method of Litchfield and Wilcoxon (1) .
In the diet experiments, four rats were maintained per cage. The metallic salt under study was dissolved in the drinking fluid. Animals consumed feed and drinking fluid ad libitum. Analyses for metals were performed on samples from three lots of feed (Purina Laboratory Chow). The feed contained (mean ± standard deviation): 56 -+-5 mg Mn/kg feed and 0.99 + 0.07 mg Pb/kg feed; the analyses of the three lots for platinum were 0.09, <0.02, and <0.02 mg Pt/kg feed. Measurements were made of the body weights of individual rats and feed and fluid consumption per cage of four rats at 7-day intervals during the course of each diet experiment.
At the termination of the dietary experiments, samples of liver were used for the isolation of microsomes. Aniline hydroxylase was measured by the method of Imai et al. (2) , modified by the addition of HgCl2 (3).
Aminopyrine demethylase was measured by the formation of formaldehyde (Nash reaction) (4) .
The analyses of the rat tissues for platinum, lead, and manganese were carried out by Yoakum, Stewart, and Sterrett (5) of Stewart Laboratories, Inc. by an emission spectrochemical method.
Results and Discussion
In Table 1 (Fig. 1A) either 1.63mM PtCl4 or Pt(SO4)2 4H20, the weight gains of the metal-treated rats was significantly less than the gains of the control rats during the first week on the diet. However, 1.63mM PtCl4 did not decrease the weight gains during the second, third or fourth weeks. The decreases of 20%o in weight gain during the first week were parallel to the decreases in feed consumption and fluid consumption which were also decreased by 20%o.
The organ weights, expressed as the percentage of the body weight, of control and metal-treated rats are given in Table 2 . PbCl2 (3.67mM) did not significantly alter the organ weights through a 30-31 day diet; the total lead intake was approximately 750 mg of lead per rat for the entire interval. ,Xg Pb/g of wet tissue in both kidney and liver. The other tissues (spleen, heart, testes, and blood) did not exhibit appreciably higher levels of Pb in the Pb-treated rats.
Soluble Pt4+ salts were included in the drinking fluid of rats for 8-9 days. The approximate total Pt intake (mg Pt per rat) and data on the tissue concentration of Pt in various tissues are presented in Table 4 . Although the Pt concentrations in tissues of untreated control rats often attain levels measurable by the technique used by Stewart Laboratories, Inc., the levels are low and are generally less than 0.1 ptg Pt/g of wet tissue.
For the higher levels of Pt4+ intake in the Pt-treated rats, the highest tissue concentrations of Pt occurred in the kidney and ranged from 4.5 to 5 MLg Pt/g of wet tissue.
High levels, ranging from 0.7 to 2.5 Mlg Pt/g, also occurred in the liver. In contrast, brain showed only a very low level of Pt which may reflect a contribution from the blood. Separate experiments were conducted on the tissue concentrations of Pt in rats which received a saturated solution of PtCl2 as the drinking fluid for 30-31 days. In the PtCl2-treated rats, the mean Pt concentration for liver, kidney, and spleen was < 0.08 ,ug Pt/g of wet tissue.
In Table 5 are presented the Pt concentrations of tissues removed from rats which had survived for the 14-day observation period in lethal-dose experiments. The doses of Pt(SO4)2 . 4H2O administered by both the oral and intraperitoneal routes were approximately 90% of the LD50 values by the respective routes. During the two-week observation period, the rats gained weight at a rate from one-third to three-fourths the rate of the control rats. In the orally treated rats, 16 ,Ag Pt/g), and appreciable levels of Pt also occurred in liver and spleen (range, [1] [2] [3] [4] ug Pt/g of wet tissue). In the intraperitoneally dosed rats, the kidney, liver, and spleen showed very high levels of Pt in the range of 10-40 ug Pt/g of wet tissue.
In a comparable lethal dose experiment, rats were treated orally with a dose of MnCl, * 4H20 equivalent to 100%o of the oral LD50 value, and the tissues were analyzed in surviving rats at the end of the 14-day observation period. In contrast to the finding with the Pt salt, the oral administration of a single, large but nonlethal dose of MnCl Environmental Health Perspectives 4H20 to rats did not result in the retention after 14 days of excess concentrations of Mn in any of the tissues analyzed (Table 6 ). Due to low levels of absorption and/or a high capacity for excretion of the Mn, the tissue Mn levels of the experimental rats were approximately equal to the levels found in control rats.
These studies show that in rats treated with soluble Pt4+ salts, appreciable levels of the metal can be found in the kidney, liver, and spleen. Further studies will be necessary to determine the effects of the Pt and other metals on various biochemical reactions.
